COVID-19 Impact on Global Drug Delivery in Cancer Market Size, Status and Forecast 2020-2026

August 2020 | 126 pages | ID: CA30618B34EFEN
QYResearch

Abstracts

This report focuses on the global Drug Delivery in Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Delivery in Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Amgen
• Teva
• UCB (Union Chimique Belge)
• Roche
• Celgene
• Sanofi
• Merck
• Johnson & Johnson
• Takeda
• Gilead Sciences
• Pfizer
• Dr Reddy
• Samyang Biopharmaceuticals
• Tolmar
• Astellas
• AMAG Pharmaceuticals
• AstraZeneca
• AbbVie
• Novartis
• Aspen
• Shire (Baxalta)
• Breckenridge Pharmaceuticals
• Galen Pharmaceuticals

Market segment by Type, the product can be split into

• Liposomes
• PEGylated Proteins & Polypeptides
• Polymer Nanoparticle
• Protein–drug Conjugates
• Others

Market segment by Application, split into

• Hospitals & Clinic
• Cancer Treatment Centers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Drug Delivery in Cancer status, future forecast, growth opportunity, key market and key players.
• To present the Drug Delivery in Cancer development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Drug Delivery in Cancer are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug Delivery in Cancer Revenue
1.4 Market Analysis by Type
  1.4.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Liposomes
  1.4.3 PEGylated Proteins & Polypeptides
  1.4.4 Polymer Nanoparticle
  1.4.5 Protein–drug Conjugates
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Drug Delivery in Cancer Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals & Clinic
  1.5.3 Cancer Treatment Centers
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Drug Delivery in Cancer Industry Impact
  1.6.1 How the Covid-19 is Affecting the Drug Delivery in Cancer Industry
    1.6.1.1 Drug Delivery in Cancer Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Drug Delivery in Cancer Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Drug Delivery in Cancer Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Drug Delivery in Cancer Market Perspective (2015-2026)
2.2 Drug Delivery in Cancer Growth Trends by Regions
  2.2.1 Drug Delivery in Cancer Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Drug Delivery in Cancer Historic Market Share by Regions (2015-2020)
  2.2.3 Drug Delivery in Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Drug Delivery in Cancer Market Growth Strategy
  2.3.6 Primary Interviews with Key Drug Delivery in Cancer Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Drug Delivery in Cancer Players by Market Size
  3.1.1 Global Top Drug Delivery in Cancer Players by Revenue (2015-2020)
  3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Players (2015-2020)
  3.1.3 Global Drug Delivery in Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drug Delivery in Cancer Market Concentration Ratio
  3.2.1 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Drug Delivery in Cancer Revenue in 2019
3.3 Drug Delivery in Cancer Key Players Head office and Area Served
3.4 Key Players Drug Delivery in Cancer Product Solution and Service
3.5 Date of Enter into Drug Delivery in Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Drug Delivery in Cancer Historic Market Size by Type (2015-2020)
4.2 Global Drug Delivery in Cancer Forecasted Market Size by Type (2021-2026)

5 DRUG DELIVERY IN CANCER BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Drug Delivery in Cancer Market Size by Application (2015-2020)
5.2 Global Drug Delivery in Cancer Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Drug Delivery in Cancer Market Size (2015-2020)
6.2 Drug Delivery in Cancer Key Players in North America (2019-2020)
6.3 North America Drug Delivery in Cancer Market Size by Type (2015-2020)
6.4 North America Drug Delivery in Cancer Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Drug Delivery in Cancer Market Size (2015-2020)
7.2 Drug Delivery in Cancer Key Players in Europe (2019-2020)
7.3 Europe Drug Delivery in Cancer Market Size by Type (2015-2020)
7.4 Europe Drug Delivery in Cancer Market Size by Application (2015-2020)

8 CHINA

8.1 China Drug Delivery in Cancer Market Size (2015-2020)
8.2 Drug Delivery in Cancer Key Players in China (2019-2020)
8.3 China Drug Delivery in Cancer Market Size by Type (2015-2020)
8.4 China Drug Delivery in Cancer Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Drug Delivery in Cancer Market Size (2015-2020)
9.2 Drug Delivery in Cancer Key Players in Japan (2019-2020)
9.3 Japan Drug Delivery in Cancer Market Size by Type (2015-2020)
9.4 Japan Drug Delivery in Cancer Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Drug Delivery in Cancer Market Size (2015-2020)
10.2 Drug Delivery in Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drug Delivery in Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Drug Delivery in Cancer Market Size by Application (2015-2020)

11 INDIA

11.1 India Drug Delivery in Cancer Market Size (2015-2020)
11.2 Drug Delivery in Cancer Key Players in India (2019-2020)
11.3 India Drug Delivery in Cancer Market Size by Type (2015-2020)
11.4 India Drug Delivery in Cancer Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Drug Delivery in Cancer Market Size (2015-2020)
12.2 Drug Delivery in Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Drug Delivery in Cancer Market Size by Type (2015-2020)
12.4 Central & South America Drug Delivery in Cancer Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Amgen
  13.1.1 Amgen Company Details
  13.1.2 Amgen Business Overview and Its Total Revenue
  13.1.3 Amgen Drug Delivery in Cancer Introduction
  13.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2015-2020))
  13.1.5 Amgen Recent Development
13.2 Teva
  13.2.1 Teva Company Details
  13.2.2 Teva Business Overview and Its Total Revenue
  13.2.3 Teva Drug Delivery in Cancer Introduction
  13.2.4 Teva Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.2.5 Teva Recent Development
13.3 UCB (Union Chimique Belge)
  13.3.1 UCB (Union Chimique Belge) Company Details
  13.3.2 UCB (Union Chimique Belge) Business Overview and Its Total Revenue
  13.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Introduction
  13.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.3.5 UCB (Union Chimique Belge) Recent Development
13.4 Roche
  13.4.1 Roche Company Details
  13.4.2 Roche Business Overview and Its Total Revenue
  13.4.3 Roche Drug Delivery in Cancer Introduction
  13.4.4 Roche Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.4.5 Roche Recent Development
13.5 Celgene
  13.5.1 Celgene Company Details
  13.5.2 Celgene Business Overview and Its Total Revenue
  13.5.3 Celgene Drug Delivery in Cancer Introduction
  13.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.5.5 Celgene Recent Development
13.6 Sanofi
  13.6.1 Sanofi Company Details
  13.6.2 Sanofi Business Overview and Its Total Revenue
  13.6.3 Sanofi Drug Delivery in Cancer Introduction
  13.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.6.5 Sanofi Recent Development
13.7 Merck
  13.7.1 Merck Company Details
  13.7.2 Merck Business Overview and Its Total Revenue
  13.7.3 Merck Drug Delivery in Cancer Introduction
  13.7.4 Merck Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.7.5 Merck Recent Development
13.8 Johnson & Johnson
  13.8.1 Johnson & Johnson Company Details
  13.8.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.8.3 Johnson & Johnson Drug Delivery in Cancer Introduction
  13.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.8.5 Johnson & Johnson Recent Development
13.9 Takeda
  13.9.1 Takeda Company Details
  13.9.2 Takeda Business Overview and Its Total Revenue
  13.9.3 Takeda Drug Delivery in Cancer Introduction
  13.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.9.5 Takeda Recent Development
13.10 Gilead Sciences
  13.10.1 Gilead Sciences Company Details
  13.10.2 Gilead Sciences Business Overview and Its Total Revenue
  13.10.3 Gilead Sciences Drug Delivery in Cancer Introduction
  13.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2015-2020)
  13.10.5 Gilead Sciences Recent Development
13.11 Pfizer
  10.11.1 Pfizer Company Details
  10.11.2 Pfizer Business Overview and Its Total Revenue
  10.11.3 Pfizer Drug Delivery in Cancer Introduction
  10.11.4 Pfizer Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.11.5 Pfizer Recent Development
13.12 Dr Reddy
  10.12.1 Dr Reddy Company Details
  10.12.2 Dr Reddy Business Overview and Its Total Revenue
  10.12.3 Dr Reddy Drug Delivery in Cancer Introduction
  10.12.4 Dr Reddy Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.12.5 Dr Reddy Recent Development
13.13 Samyang Biopharmaceuticals
  10.13.1 Samyang Biopharmaceuticals Company Details
  10.13.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue
  10.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Introduction
  10.13.4 Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.13.5 Samyang Biopharmaceuticals Recent Development
13.14 Tolmar
  10.14.1 Tolmar Company Details
  10.14.2 Tolmar Business Overview and Its Total Revenue
  10.14.3 Tolmar Drug Delivery in Cancer Introduction
  10.14.4 Tolmar Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.14.5 Tolmar Recent Development
13.15 Astellas
  10.15.1 Astellas Company Details
  10.15.2 Astellas Business Overview and Its Total Revenue
  10.15.3 Astellas Drug Delivery in Cancer Introduction
  10.15.4 Astellas Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.15.5 Astellas Recent Development
13.16 AMAG Pharmaceuticals
  10.16.1 AMAG Pharmaceuticals Company Details
  10.16.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
  10.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Introduction
  10.16.4 AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.16.5 AMAG Pharmaceuticals Recent Development
13.17 AstraZeneca
  10.17.1 AstraZeneca Company Details
  10.17.2 AstraZeneca Business Overview and Its Total Revenue
  10.17.3 AstraZeneca Drug Delivery in Cancer Introduction
  10.17.4 AstraZeneca Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.17.5 AstraZeneca Recent Development
13.18 AbbVie
  10.18.1 AbbVie Company Details
  10.18.2 AbbVie Business Overview and Its Total Revenue
  10.18.3 AbbVie Drug Delivery in Cancer Introduction
  10.18.4 AbbVie Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.18.5 AbbVie Recent Development
13.19 Novartis
  10.19.1 Novartis Company Details
  10.19.2 Novartis Business Overview and Its Total Revenue
  10.19.3 Novartis Drug Delivery in Cancer Introduction
  10.19.4 Novartis Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.19.5 Novartis Recent Development
13.20 Aspen
  10.20.1 Aspen Company Details
  10.20.2 Aspen Business Overview and Its Total Revenue
  10.20.3 Aspen Drug Delivery in Cancer Introduction
  10.20.4 Aspen Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.20.5 Aspen Recent Development
13.21 Shire (Baxalta)
  10.21.1 Shire (Baxalta) Company Details
  10.21.2 Shire (Baxalta) Business Overview and Its Total Revenue
  10.21.3 Shire (Baxalta) Drug Delivery in Cancer Introduction
  10.21.4 Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.21.5 Shire (Baxalta) Recent Development
13.22 Breckenridge Pharmaceuticals
  10.22.1 Breckenridge Pharmaceuticals Company Details
  10.22.2 Breckenridge Pharmaceuticals Business Overview and Its Total Revenue
  10.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Introduction
  10.22.4 Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.22.5 Breckenridge Pharmaceuticals Recent Development
13.23 Galen Pharmaceuticals
  10.23.1 Galen Pharmaceuticals Company Details
  10.23.2 Galen Pharmaceuticals Business Overview and Its Total Revenue
  10.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Introduction
  10.23.4 Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2015-2020)
  10.23.5 Galen Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Drug Delivery in Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Drug Delivery in Cancer Revenue
Table 3. Ranking of Global Top Drug Delivery in Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drug Delivery in Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liposomes
Table 6. Key Players of PEGylated Proteins & Polypeptides
Table 7. Key Players of Polymer Nanoparticle
Table 8. Key Players of Protein–drug Conjugates
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Drug Delivery in Cancer Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Drug Delivery in Cancer Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Drug Delivery in Cancer Players to Combat Covid-19 Impact
Table 15. Global Drug Delivery in Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Drug Delivery in Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Drug Delivery in Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Drug Delivery in Cancer Market Share by Regions (2015-2020)
Table 19. Global Drug Delivery in Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Drug Delivery in Cancer Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Drug Delivery in Cancer Market Growth Strategy
Table 25. Main Points Interviewed from Key Drug Delivery in Cancer Players
Table 26. Global Drug Delivery in Cancer Revenue by Players (2015-2020) (Million US$)
Table 27. Global Drug Delivery in Cancer Market Share by Players (2015-2020)
Table 28. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery in Cancer as of 2019)
Table 29. Global Drug Delivery in Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Drug Delivery in Cancer Product Solution and Service
Table 32. Date of Enter into Drug Delivery in Cancer Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Drug Delivery in Cancer Market Size by Type (2015-2020) (Million US$)
Table 35. Global Drug Delivery in Cancer Market Size Share by Type (2015-2020)
Table 36. Global Drug Delivery in Cancer Revenue Market Share by Type (2021-2026)
Table 37. Global Drug Delivery in Cancer Market Size Share by Application (2015-2020)
Table 38. Global Drug Delivery in Cancer Market Size by Application (2015-2020) (Million US$)
Table 39. Global Drug Delivery in Cancer Market Size Share by Application (2021-2026)
Table 40. North America Key Players Drug Delivery in Cancer Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Drug Delivery in Cancer Market Share (2019-2020)
Table 42. North America Drug Delivery in Cancer Market Size by Type (2015-2020) (Million US$)
Table 43. North America Drug Delivery in Cancer Market Share by Type (2015-2020)
Table 44. North America Drug Delivery in Cancer Market Size by Application (2015-2020) (Million US$)
Table 45. North America Drug Delivery in Cancer Market Share by Application (2015-2020)
Table 46. Europe Key Players Drug Delivery in Cancer Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Drug Delivery in Cancer Market Share (2019-2020)
Table 48. Europe Drug Delivery in Cancer Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Drug Delivery in Cancer Market Share by Type (2015-2020)
Table 50. Europe Drug Delivery in Cancer Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Drug Delivery in Cancer Market Share by Application (2015-2020)
Table 52. China Key Players Drug Delivery in Cancer Revenue (2019-2020) (Million US$)
Table 53. China Key Players Drug Delivery in Cancer Market Share (2019-2020)
Table 54. China Drug Delivery in Cancer Market Size by Type (2015-2020) (Million US$)
Table 55. China Drug Delivery in Cancer Market Share by Type (2015-2020)
Table 56. China Drug Delivery in Cancer Market Size by Application (2015-2020) (Million US$)
Table 57. China Drug Delivery in Cancer Market Share by Application (2015-2020)
Table 58. Japan Key Players Drug Delivery in Cancer Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Drug Delivery in Cancer Market Share (2019-2020)
Table 60. Japan Drug Delivery in Cancer Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Drug Delivery in Cancer Market Share by Type (2015-2020)
Table 62. Japan Drug Delivery in Cancer Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Drug Delivery in Cancer Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Drug Delivery in Cancer Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Drug Delivery in Cancer Market Share (2019-2020)
Table 66. Southeast Asia Drug Delivery in Cancer Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Drug Delivery in Cancer Market Share by Type (2015-2020)
Table 68. Southeast Asia Drug Delivery in Cancer Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Drug Delivery in Cancer Market Share by Application (2015-2020)
Table 70. India Key Players Drug Delivery in Cancer Revenue (2019-2020) (Million US$)
Table 71. India Key Players Drug Delivery in Cancer Market Share (2019-2020)
Table 72. India Drug Delivery in Cancer Market Size by Type (2015-2020) (Million US$)
Table 73. India Drug Delivery in Cancer Market Share by Type (2015-2020)
Table 74. India Drug Delivery in Cancer Market Size by Application (2015-2020) (Million US$)
Table 75. India Drug Delivery in Cancer Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Drug Delivery in Cancer Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Drug Delivery in Cancer Market Share (2019-2020)
Table 78. Central & South America Drug Delivery in Cancer Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Drug Delivery in Cancer Market Share by Type (2015-2020)
Table 80. Central & South America Drug Delivery in Cancer Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Drug Delivery in Cancer Market Share by Application (2015-2020)
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Product
Table 85. Amgen Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 86. Amgen Recent Development
Table 87. Teva Company Details
Table 88. Teva Business Overview
Table 89. Teva Product
Table 90. Teva Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 91. Teva Recent Development
Table 92. UCB (Union Chimique Belge) Company Details
Table 93. UCB (Union Chimique Belge) Business Overview
Table 94. UCB (Union Chimique Belge) Product
Table 95. UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 96. UCB (Union Chimique Belge) Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Product
Table 100. Roche Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 101. Roche Recent Development
Table 102. Celgene Company Details
Table 103. Celgene Business Overview
Table 104. Celgene Product
Table 105. Celgene Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 106. Celgene Recent Development
Table 107. Sanofi Company Details
Table 108. Sanofi Business Overview
Table 109. Sanofi Product
Table 110. Sanofi Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 111. Sanofi Recent Development
Table 112. Merck Company Details
Table 113. Merck Business Overview
Table 114. Merck Product
Table 115. Merck Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 116. Merck Recent Development
Table 117. Johnson & Johnson Business Overview
Table 118. Johnson & Johnson Product
Table 119. Johnson & Johnson Company Details
Table 120. Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 121. Johnson & Johnson Recent Development
Table 122. Takeda Company Details
Table 123. Takeda Business Overview
Table 124. Takeda Product
Table 125. Takeda Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 126. Takeda Recent Development
Table 127. Gilead Sciences Company Details
Table 128. Gilead Sciences Business Overview
Table 129. Gilead Sciences Product
Table 130. Gilead Sciences Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 131. Gilead Sciences Recent Development
Table 132. Pfizer Company Details
Table 133. Pfizer Business Overview
Table 134. Pfizer Product
Table 135. Pfizer Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 136. Pfizer Recent Development
Table 137. Dr Reddy Company Details
Table 138. Dr Reddy Business Overview
Table 139. Dr Reddy Product
Table 140. Dr Reddy Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 141. Dr Reddy Recent Development
Table 142. Samyang Biopharmaceuticals Company Details
Table 143. Samyang Biopharmaceuticals Business Overview
Table 144. Samyang Biopharmaceuticals Product
Table 145. Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 146. Samyang Biopharmaceuticals Recent Development
Table 147. Tolmar Company Details
Table 148. Tolmar Business Overview
Table 149. Tolmar Product
Table 150. Tolmar Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 151. Tolmar Recent Development
Table 152. Astellas Company Details
Table 153. Astellas Business Overview
Table 154. Astellas Product
Table 155. Astellas Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 156. Astellas Recent Development
Table 157. AMAG Pharmaceuticals Company Details
Table 158. AMAG Pharmaceuticals Business Overview
Table 159. AMAG Pharmaceuticals Product
Table 160. AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 161. AMAG Pharmaceuticals Recent Development
Table 162. AstraZeneca Company Details
Table 163. AstraZeneca Business Overview
Table 164. AstraZeneca Product
Table 165. AstraZeneca Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 166. AstraZeneca Recent Development
Table 167. AbbVie Company Details
Table 168. AbbVie Business Overview
Table 169. AbbVie Product
Table 170. AbbVie Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 171. AbbVie Recent Development
Table 172. Novartis Company Details
Table 173. Novartis Business Overview
Table 174. Novartis Product
Table 175. Novartis Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 176. Novartis Recent Development
Table 177. Aspen Company Details
Table 178. Aspen Business Overview
Table 179. Aspen Product
Table 180. Aspen Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 181. Aspen Recent Development
Table 182. Shire (Baxalta) Company Details
Table 183. Shire (Baxalta) Business Overview
Table 184. Shire (Baxalta) Product
Table 185. Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 186. Shire (Baxalta) Recent Development
Table 187. Breckenridge Pharmaceuticals Company Details
Table 188. Breckenridge Pharmaceuticals Business Overview
Table 189. Breckenridge Pharmaceuticals Product
Table 190. Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 191. Breckenridge Pharmaceuticals Recent Development
Table 192. Galen Pharmaceuticals Company Details
Table 193. Galen Pharmaceuticals Business Overview
Table 194. Galen Pharmaceuticals Product
Table 195. Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2015-2020) (Million US$)
Table 196. Galen Pharmaceuticals Recent Development
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Drug Delivery in Cancer Market Share by Type: 2020 VS 2026
Figure 2. Liposomes Features
Figure 3. PEGylated Proteins & Polypeptides Features
Figure 4. Polymer Nanoparticle Features
Figure 5. Protein–drug Conjugates Features
Figure 6. Others Features
Figure 7. Global Drug Delivery in Cancer Market Share by Application: 2020 VS 2026
Figure 8. Hospitals & Clinic Case Studies
Figure 9. Cancer Treatment Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Drug Delivery in Cancer Report Years Considered
Figure 12. Global Drug Delivery in Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Drug Delivery in Cancer Market Share by Regions: 2020 VS 2026
Figure 14. Global Drug Delivery in Cancer Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Drug Delivery in Cancer Market Share by Players in 2019
Figure 17. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Delivery in Cancer as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Drug Delivery in Cancer Revenue in 2019
Figure 19. North America Drug Delivery in Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Drug Delivery in Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Drug Delivery in Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Drug Delivery in Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Drug Delivery in Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Drug Delivery in Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Drug Delivery in Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amgen Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 28. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Teva Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 30. UCB (Union Chimique Belge) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. UCB (Union Chimique Belge) Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 34. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Celgene Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 36. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Sanofi Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 38. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Merck Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 40. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Johnson & Johnson Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 42. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Takeda Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 44. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Gilead Sciences Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 46. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Pfizer Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 48. Dr Reddy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Dr Reddy Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 50. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Samyang Biopharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 52. Tolmar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Tolmar Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 54. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Astellas Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 56. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. AMAG Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 58. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. AstraZeneca Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 60. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. AbbVie Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 62. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Novartis Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 64. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Aspen Revenue Growth Rate in Drug Delivery in Cancer Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed